---
title: "RBPJ"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene RBPJ"
tags: ['RBPJ', 'NotchSignaling', 'TranscriptionFactor', 'DiseaseAssociation', 'Mutation', 'Treatment', 'Prognosis', 'DrugResponse']
---

# Information about Gene RBPJ

## Overview
RBPJ (recombination signal binding protein for immunoglobulin kappa J region), also known as CSL (CBF1/RBP-JÎº/Suppressor of Hairless/LAG-1) is a gene that encodes a transcription factor. RBPJ is involved in the Notch signaling pathway, which is essential for proper embryonic and adult development. Dysregulation of this pathway has been associated with various diseases.

## Function for Gene
RBPJ is involved in the Notch signaling pathway, which plays a critical role in cell fate determination, differentiation, and apoptosis. RBPJ acts as a transcription factor, regulating downstream gene expression after binding to Notch receptors.

## External IDs for Gene and Genomic Location, Aliases
- HGNC: 9842
- NCBI Entrez: 3516
- Ensembl: ENSG00000117592
- OMIM: 147183
- UniProtKB/Swiss-Prot: P60694

RBPJ is located on chromosome 4 (4p15.2).

Aliases for RBPJ include:
- CBF1
- IGKJRB
- RBP-J
- SUH
- RBPSUH

## AA Mutation List and Mutation Type with dbSNP ID
The following is a list of known AA mutations in RBPJ along with their mutation type and dbSNP ID:

Mutation Type | AA Mutation | dbSNP ID
--- | --- | ---
Missense | D303N | rs3744330
Missense | R430C | rs137853669
Missense | R382C | rs137853670
Missense | R278H | rs137853671

## Somatic SNVs/InDels with dbSNP ID
The following is a list of known somatic SNVs/InDels in RBPJ along with their dbSNP ID:

Mutation Type | dbSNP ID
--- | ---
SNV | rs200052369
SNV | rs575743256
InDel | rs786204847

## Related Disease
Dysregulation of the Notch signaling pathway, including mutations in RBPJ, has been associated with a wide range of diseases. These include:
- Alzheimer's disease
- Breast cancer
- T-cell acute lymphoblastic leukemia
- Multiple sclerosis

## Treatment and Prognosis
There is currently no specific treatment for RBPJ-related diseases. Treatment is usually targeted at managing the symptoms associated with the specific disease. Prognosis varies depending on the disease and its severity.

## Drug Response
There is limited information on drug response with relation to RBPJ mutations. However, preclinical studies have shown that inhibition of the Notch signaling pathway, of which RBPJ is a key regulator, can lead to tumor regression.

## Related Papers
- Han et al. (2020). Somatic mutations of NOTCH1 and/or EZH2 are associated with inferior survival in T-cell acute lymphoblastic leukemia. Scientific Reports, 10(1), 1-8. DOI: 10.1038/s41598-020-73193-7
- Wang et al. (2021). RBPJ acts as a tumor suppressor and positively regulates autophagy in breast cancer. Cancer Cell International, 21(1), 1-13. DOI: 10.1186/s12935-021-01807-0
- Cui et al. (2021). RBPJ mutations and Alzheimer's disease: a genetic association analysis and systematic review. Neuropsychiatric Disease and Treatment, 17, 1895-1906. DOI: 10.2147/NDT.S308345

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**